BioSpace News Archive

Business

Shockwave Medical Reports Third Quarter 2023 Financial Results

Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular disease, today reported financial results for the three months ended September 30, 2023.

November 6, 2023
·
10 min read
Biotech Bay

Invitae Launches Enhanced Chemistry of MRD Test to Better Serve Biopharmaceutical Clinical and Research Partnerships

Invitae, a leading medical genetics company, announced enhanced chemistry of its Invitae Personalized Cancer Monitoring™ platform that helps detect circulating tumor DNA as a biomarker for solid tumor malignancies.

November 6, 2023
·
6 min read
Business

TransMedics Reports Third Quarter 2023 Financial Results

TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today reported financial results for the quarter ended September 30, 2023.

November 6, 2023
·
9 min read
BioMidwest

Align Technology Opens 2024 Annual Research Program to Advance Orthodontic and Dental Patient Care

Align Technology, Inc. announced the opening of its 2024 Annual Research Award Program to support clinical and scientific dental research in universities across the globe.

November 6, 2023
·
3 min read
Business

NanoString Technologies Releases Operating Results for Third Quarter of 2023

NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the third quarter ended September 30, 2023.

November 6, 2023
·
17 min read
Business

Acorda Third Quarter 2023 Update: Webcast/Conference Call Scheduled for November 13, 2023

Acorda Therapeutics, Inc. will host a webcast/conference call in conjunction with its third quarter 2023 update and financial results on Monday, November 13 at 4:30 p.m. ET.

November 6, 2023
·
4 min read
Business

Vertex Reports Third Quarter 2023 Financial Results

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the third quarter ended September 30, 2023, raised full year 2023 guidance for product revenue and reiterated full year 2023 guidance for operating expenses.

November 6, 2023
·
26 min read
Business

CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial Results

CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today reported financial results for the third quarter ended September 30, 2023.

November 6, 2023
·
19 min read
Business

Coherus BioSciences Reports Third Quarter 2023 Financial Results and Business Highlights

Coherus BioSciences, Inc. (Coherus, Nasdaq: CHRS), today reported financial results for the quarter ended September 30, 2023, and recent business highlights.

November 6, 2023
·
19 min read
Business

ATEC Reports Third Quarter 2023 Financial Results and Raises Full Year 2023 Adjusted EBITDA Guidance

Alphatec Holdings, Inc., a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced financial results for the quarter ended September 30, 2023, and recent corporate highlights.

November 6, 2023
·
11 min read